Applies to Employer and ACA Marketplace plans.
Covered with requirementsQualification pathways
You can qualify through any one of these.
OSA with Obesity
All of:
- Diagnosis of moderate to severe obstructive sleep apnea
- Obesity (BMI ≥ 30 kg/m2)
- Age ≥ 18 years old
- Current baseline weight documented
- Physician attestation that member will participate in lifestyle modifications to promote weight loss (healthy eating, exercise if appropriate)
- Not to be used in combination with other weight loss products
- Cannot be used in combination with other GLP-1 agonist containing products
Documentation to bring
- Diagnosis of moderate to severe obstructive sleep apnea
- BMI documentation ≥ 30 kg/m2
- Current baseline weight
- Physician attestation that member will participate in lifestyle modifications to promote weight loss
- For continuation: Current weight (within 30 days)
- For continuation: Physician attestation of ≥ 5% weight loss from baseline and continued active participation in lifestyle modifications
Approval and renewal
- Initial approval: 12 months
- Renewal: every 12 months
- Renewal: Physician attestation that member maintains at least 5% weight loss from baseline; current weight must be submitted to plan; attestation of continued active participation in lifestyle modifications supporting weight loss.
Not covered when
- Cannot be used in combination with other weight loss products
- Cannot be used in combination with other GLP-1 agonist containing products
Policy note: The OSA indication is listed under the Pathway 1 group benefit section as an alternative qualifying criterion. The document states 'Treatment of moderate to severe obstructive sleep apnea in adults with obesity (BMI 30 kg/m2 or greater)'. No minimum AHI threshold is specified, and no PAP/CPAP trial requirement is stated. The same continuation criteria as the weight loss Pathway 1 apply (5% weight loss from baseline). Coverage is subject to group benefit determination.
Policy effective June 1, 2026 · verified June 2, 2026 · source: Prior Authorization And Step Therapy Guidelines · View policy document (PDF)